|
|
|
|
|
09.10.25 - 13:06
|
Biopharma Leaders Advance the Future of Life Sciences at Veeva Commercial Summit Europe (PR Newswire)
|
|
|
Industry gathers to explore Veeva AI innovations and exchange ideas with companies including Astellas, Bayer AG, Boehringer Ingelheim, LEO Pharma, Moderna, and MSD BARCELONA, Spain, Oct. 9, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Astellas, Bayer AG, Boehringer......
|
|
|
|
|
|
|
08.10.25 - 09:03
|
Clustermarket Rebrands to Calira and Secures Industry Veteran to Capitalise on Demand for Optimised R&D Lab Operations (Business Wire)
|
|
|
Lab equipment scheduling platform supporting pharma and life sciences R&D organisations' AI journey amidst industry upheavalLONDON--(BUSINESS WIRE)--Clustermarket, the lab equipment scheduling platform, has today announced it is rebranding to Calira and welcoming non-executive director and investor Edmund Wilson, co-founder and former CEO of Titian Software (now Cenevo), to capitalise on increasing enterprise demand for optimising lab operations.
The company's software has been popular with academic institutions and SMBs for several years, but has seen a recent upsurge in interest from enterprise research and development organisations—such as Merck (MSD), Moderna, Eli Lilly, Takeda and Lonza—as pharma and life sciences companies navigate market turmoil. This follows wider industry data that shows global biopharma lay-offs rose 63% in 2024 compared to 2022.
This disruption is forcing businesses to look at return on investment in R&D, and Calira says this will put increased pressure on LabOps teams to...
|
|
|
|
|
07.10.25 - 08:03
|
Epsilogen Announces the Appointment of Cristina Oliva, MD, PhD as Chief Medical Officer (Business Wire)
|
|
|
Board-certified oncologist who brings over 20 years of senior clinical development experience across large pharmaceutical, biotechnology and Clinical Research OrganizationsLONDON--(BUSINESS WIRE)--Epsilogen, the world's leading pan-isotype antibody therapeutic company for the treatment of cancer, today announces the appointment of Cristina Oliva, MD, PhD, as Chief Medical Officer. Dr. Oliva is a Board-certified oncologist and brings global experience across all stages of oncology drug development.
Dr. Oliva joins Epsilogen from BerGenBio, where she served as Chief Medical Officer from 2022. Prior to this role, Dr. Oliva was Vice President, Oncology and Head of Oncology Centre of Excellence at IQVIA, where she led a cross-functional team of oncology subject matter experts and established and led the IQVIA Oncology Global Scientific Advisory Board. Dr. Oliva has also held senior positions, leading oncology development programs, at Nordic Nanovector, Takeda Pharmaceuticals, GSK and Eli Lilly.
Tim Wilson, CE...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
03.10.25 - 14:09
|
Trump Admin Pushing For More AI, Energy, & Pharma Corporate Deals Ahead of Midterms (ZeroHedge)
|
|
|
Trump Admin Pushing For More AI, Energy, & Pharma Corporate Deals Ahead of Midterms
As part of America's Industrial Policy transformation, Thetrump administration is pressing companies across nearly 30 industries to strike deals that advance national and economic security goals, Reuters reported.
Officials are offering tariff relief, revenue guarantees, and even government equity stakes in exchange for concessions. The rapid pace of negotiations is aimed at securing political wins for President Donald Trump before the 2026 midterm elections, the sources said. Stocks like USA Rare Earth (USAR), Lithium Corporation (LTUM), Centrus (LEU) and other appear to be moving higher mid-day Thursday on the news and speculation of which companies could be targeted.
Commerce Secretary Howard Lutnick has emerged as the administration's lead dealmaker, overseeing government stakes in Intel and Nippon Steel's purchase of U.S. Steel. “If we're going to give you the money, we want a piece of the action,?...
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
